3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Conditions
Prostatic Neoplasms
12
Neoplasms
11
Neuroendocrine Tumors
9
Breast Neoplasms
9
Lung Neoplasms
6
Neoplasm Metastasis
4
Multiple Myeloma
4
Disease
4
Uterine Cervical Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Head and Neck Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Mouth Neoplasms
2
Lymphoma, Follicular
2
Liver Neoplasms
2
Leukemia
2
Hypoxia
2
Hodgkin Disease
2
Glioma
2
Esophageal Neoplasms
2
Carcinoma, Neuroendocrine
2
Brain Neoplasms
2
Interventions
Ifosfamide
30
Methotrexate
27
Doxorubicin
25
Cyclophosphamide
24
Cisplatin
22
Filgrastim
18
Etoposide
17
Gemcitabine
16
Leucovorin
14
Magnetic Resonance Spectroscopy
11
Temozolomide
10
cabozantinib
9
apatinib
9
Specimen Handling
9
Carboplatin
9
fludarabine
8
X-Rays
8
Nivolumab
8
Neoadjuvant Therapy
8
Irinotecan
8
Granulocyte Colony-Stimulating Factor
8
Docetaxel
8
Zoledronic Acid
7
Vincristine
7
Sirolimus
7
Radiotherapy
7
Phantoms, Imaging
7
Biopsy
7
Topotecan
6
Mesna
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Osteosarcoma
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled